{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T12:45:58Z","timestamp":1791463558832,"version":"4.3.4"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T00:00:00Z","timestamp":1735257600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011360","name":"China Pharmaceutical University State Key Laboratory Of Natural Medicines","doi-asserted-by":"publisher","award":["SKLNMKF202302"],"award-info":[{"award-number":["SKLNMKF202302"]}],"id":[{"id":"10.13039\/501100011360","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32141004,82100746"],"award-info":[{"award-number":["32141004,82100746"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.ebiom.2024.105553","type":"journal-article","created":{"date-parts":[[2025,1,11]],"date-time":"2025-01-11T05:05:49Z","timestamp":1736571949000},"page":"105553","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Aurora kinase B inhibitor AZD1152: repurposing for treatment of lupus nephritis driven by the results of clinical trials"],"prefix":"10.1016","volume":"112","author":[{"given":"Yue","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuguo","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuexiao","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoshan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingchao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6093-0726","authenticated-orcid":false,"given":"Zhihong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ebiom.2024.105553_bib1","first-page":"1","article-title":"Systemic lupus erythematosus: State of the art on clinical practice guidelines","volume":"4","author":"Tamirou","year":"2018","journal-title":"RMD Open"},{"issue":"8","key":"10.1016\/j.ebiom.2024.105553_bib2","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1093\/rheumatology\/ker101","article-title":"Assessment of a lupus nephritis cohort over a 30-year period","volume":"50","author":"Croca","year":"2011","journal-title":"Rheumatology"},{"key":"10.1016\/j.ebiom.2024.105553_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2022.102871","article-title":"Lupus nephritis: new progress in diagnosis and treatment","volume":"132","author":"Yu","year":"2022","journal-title":"J\u00a0Autoimmun"},{"issue":"2","key":"10.1016\/j.ebiom.2024.105553_bib4","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.kint.2021.09.012","article-title":"The lupus nephritis management renaissance","volume":"101","author":"Mejia-Vilet","year":"2022","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105553_bib5","doi-asserted-by":"crossref","first-page":"18","DOI":"10.7326\/M14-1030","article-title":"Multitarget therapy for induction treatment of lupus nephritis: a randomized trial","volume":"162","author":"Liu","year":"2015","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.ebiom.2024.105553_bib6","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.kint.2017.08.031","article-title":"Transcriptomic analysis uncovers novel synergistic mechanisms in combination therapy for lupus nephritis","volume":"93","author":"Fu","year":"2018","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105553_bib7","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.kint.2017.12.026","article-title":"Drug repurposing in kidney disease","volume":"94","author":"Panchapakesan","year":"2018","journal-title":"Kidney Int"},{"issue":"10","key":"10.1016\/j.ebiom.2024.105553_bib8","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1016\/j.drudis.2019.06.014","article-title":"Drug repurposing: a promising tool to accelerate the drug discovery process","volume":"24","author":"Parvathaneni","year":"2019","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.ebiom.2024.105553_bib9","first-page":"1929","article-title":"The connectivity Map : using gene-expression signatures to connect small molecules, genes, and disease","volume":"313","author":"Molecules","year":"2006","journal-title":"Science (1979)"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105553_bib10","first-page":"139","article-title":"A next generation connectivity Map: L1000 platform and the first 1,000,000 profiles","volume":"176","author":"Teeple","year":"2017","journal-title":"Cell"},{"issue":"20","key":"10.1016\/j.ebiom.2024.105553_bib11","doi-asserted-by":"crossref","first-page":"5690","DOI":"10.1158\/0008-5472.CAN-13-3540","article-title":"Novel drug candidates for the treatment of metastatic colorectal cancer through global inverse gene-expression profiling","volume":"74","author":"Van Noort","year":"2014","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105553_bib12","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.kint.2020.01.029","article-title":"Connectivity mapping of a chronic kidney disease progression signature identified lysine deacetylases as novel therapeutic targets","volume":"98","author":"Williams","year":"2020","journal-title":"Kidney Int"},{"issue":"6","key":"10.1016\/j.ebiom.2024.105553_bib13","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/sj.bjc.6602779","article-title":"Overexpression of aurora B kinase (AURKB) in primary non-small cell lung carcinoma is frequent, generally driven from one allele, and correlates with the level of genetic instability","volume":"93","author":"Smith","year":"2005","journal-title":"Br J Cancer"},{"issue":"4","key":"10.1016\/j.ebiom.2024.105553_bib14","doi-asserted-by":"crossref","first-page":"482","DOI":"10.2174\/092986711794480203","article-title":"A\u00a0new prognostic marker and therapeutic target in cancer","volume":"18","author":"Portella","year":"2011","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.ebiom.2024.105553_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2017.08.045","article-title":"A\u00a0comprehensive review on Aurora kinase: small molecule inhibitors and clinical trial studies","volume":"140","author":"Borisa","year":"2017","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.ebiom.2024.105553_bib16","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/356314a0","article-title":"Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis","volume":"356","author":"Watanabe-Fukunaga","year":"1992","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105553_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-017-02672-0","article-title":"NF-\u03baB inducing kinase is a therapeutic target for systemic lupus erythematosus","volume":"9","author":"Brightbill","year":"2018","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.ebiom.2024.105553_bib18","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/cmi.2018.1","article-title":"MicroRNA-663 induces immune dysregulation by inhibiting TGF-\u03b21 production in bone marrow-derived mesenchymal stem cells in patients with systemic lupus erythematosus","volume":"16","author":"Geng","year":"2019","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.ebiom.2024.105553_bib19","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/s41586-020-2121-3","article-title":"Metabolites released from apoptotic cells act as tissue messengers","volume":"580","author":"Medina","year":"2020","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.ebiom.2024.105553_bib20","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1158\/0008-5472.CAN-08-3133","article-title":"A\u00a0high throughput, whole cell screen for small molecule inhibitors of the mitotic spindle checkpoint identifies OM137, a novel aurora kinase inhibitor","volume":"69","author":"Demoe","year":"2009","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105553_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000511268","article-title":"Update on lupus nephritis: looking for a new vision","volume":"145","author":"Morales","year":"2021","journal-title":"Nephron"},{"issue":"4","key":"10.1016\/j.ebiom.2024.105553_bib22","doi-asserted-by":"crossref","first-page":"4414","DOI":"10.1021\/acsnano.9b09998","article-title":"MicroRNA-125a-Loaded polymeric nanoparticles alleviate systemic lupus erythematosus by restoring effector\/regulatory T cells balance","volume":"14","author":"Zhang","year":"2020","journal-title":"ACS Nano"},{"issue":"4","key":"10.1016\/j.ebiom.2024.105553_bib23","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.molmed.2018.02.003","article-title":"Mechanisms of tissue injury in lupus nephritis","volume":"24","author":"Flores-Mendoza","year":"2018","journal-title":"Trends Mol Med"},{"issue":"3","key":"10.1016\/j.ebiom.2024.105553_bib24","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1182\/blood.V100.3.982","article-title":"Regulation of leukemic cell adhesion, proliferation, and survival by \u03b2-catenin","volume":"100","author":"Chung","year":"2002","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.ebiom.2024.105553_bib25","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/art.40729","article-title":"All-cause and cause-specific mortality trends of end-stage renal disease due to lupus nephritis from 1995 to 2014","volume":"71","author":"Jorge","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.ebiom.2024.105553_bib26","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ebiom.2018.05.034","article-title":"Mesenchymal stem cells control complement C5 activation by factor H in lupus nephritis","volume":"32","author":"Ma","year":"2018","journal-title":"EBioMedicine"},{"issue":"2","key":"10.1016\/j.ebiom.2024.105553_bib27","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/bph.14081","article-title":"Inventing new therapies without reinventing the wheel: the power of drug repurposing","volume":"175","author":"Papapetropoulos","year":"2018","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.ebiom.2024.105553_bib28","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/s41581-024-00864-8","article-title":"Drug repurposing for glomerular diseases: an underutilized resource","volume":"20","author":"Ng","year":"2024","journal-title":"Nat Rev Nephrol"},{"issue":"23","key":"10.1016\/j.ebiom.2024.105553_bib29","doi-asserted-by":"crossref","first-page":"6030","DOI":"10.1182\/blood-2011-07-366930","article-title":"Phase 1\/2 study to assess the safety, efficacy, and pharmacokinetics of barasertib (AZD1152) in patients with advanced acute myeloid leukemia","volume":"118","author":"L\u00f6wenberg","year":"2011","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.ebiom.2024.105553_bib30","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1093\/annonc\/mdq344","article-title":"Clinical evaluation of AZD1152, an i.v. inhibitor of Aurora B kinase, in patients with solid malignant tumors","volume":"22","author":"Boss","year":"2011","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ebiom.2024.105553_bib31","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41586-022-04642-z","article-title":"TLR7 gain-of-function genetic variation causes human lupus","volume":"605","author":"Brown","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2024.105553_bib32","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.clim.2016.08.001","article-title":"Lupus nephritis biomarkers","volume":"185","author":"Soliman","year":"2017","journal-title":"Clin Immunol"},{"issue":"5","key":"10.1016\/j.ebiom.2024.105553_bib33","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1136\/ard-2023-224788","article-title":"Single-cell profiling reveals kidney CD163+ dendritic cell participation in human lupus nephritis","volume":"83","author":"Chen","year":"2024","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.ebiom.2024.105553_bib34","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1038\/ki.2012.242","article-title":"Kidney-infiltrating CD4 T-cell clones promote nephritis in lupus-prone mice","volume":"82","author":"Okamoto","year":"2012","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105553_bib35","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ymthe.2022.09.013","article-title":"NAMPT is a metabolic checkpoint of IFN\u03b3-producing CD4+ T cells in lupus nephritis","volume":"31","author":"Li","year":"2023","journal-title":"Mol Ther"},{"issue":"12","key":"10.1016\/j.ebiom.2024.105553_bib36","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.138345","article-title":"Integrated urine proteomics and renal single-cell genomics identify an IFN-\u03b3 response gradient in lupus nephritis","volume":"5","author":"Fava","year":"2020","journal-title":"JCI Insight"},{"issue":"2","key":"10.1016\/j.ebiom.2024.105553_bib37","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1172\/JCI750","article-title":"Interferon-\u03b3 is required for lupus-like disease and lymphoaccumulation in MRL-lpr mice","volume":"101","author":"Balomenos","year":"1998","journal-title":"J\u00a0Clin Invest"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105553_bib38","doi-asserted-by":"crossref","first-page":"494","DOI":"10.4049\/jimmunol.161.1.494","article-title":"IFN-\u03b3 receptor signaling is essential for the initiation, acceleration, and destruction of autoimmune kidney disease in MRL- Fas lpr mice","volume":"161","author":"Schwarting","year":"1998","journal-title":"J\u00a0Immunol"},{"issue":"5","key":"10.1016\/j.ebiom.2024.105553_bib39","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/onc.2014.14","article-title":"The aurora kinases in cell cycle and leukemia","volume":"34","author":"Goldenson","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.ebiom.2024.105553_bib40","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jaut.2018.08.006","article-title":"CRL4 DCAF2 is required for mature T-cell expansion via Aurora B-regulated proteasome activity","volume":"96","author":"Fan","year":"2019","journal-title":"J\u00a0Autoimmun"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396424005899?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396424005899?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T19:37:48Z","timestamp":1778873868000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396424005899"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":40,"alternative-id":["S2352396424005899"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2024.105553","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aurora kinase B inhibitor AZD1152: repurposing for treatment of lupus nephritis driven by the results of clinical trials","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2024.105553","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105553"}}